Figure 7
Analysis of secondary metabolites content and HMGR transcript expression levels in transiently transformed tissues of O. kilimandscharicum in presence and absence of inhibitors. (A) mRNA transcript levels and (B) Total essential oil content (μg g−1) in O. kilimandscharicum. Control- untransformed tissue without inhibitor, Vector control- pCAMBIA1303 vector transformed tissue without inhibitor, HMGR ox- transformed tissue without inhibitor treatment, Control + P- untransformed tissue with pravastatin treatment, Vector control + P- vector transformed tissue with pravastatin treatment, HMGR ox + P- transformed tissue with pravastatin treatment, Control + M- untransformed tissue with mevastatin treatment, Vector control + M- vector transformed tissue with mevastatin treatment and HMGR ox + M- transformed tissue with mevastatin treatment.
